Clinical investigation of medicinal products to prevent development/slow progression of chronic renal insufficiency
| Current effective version |
|
| Reference number | EMA/CHMP/500825/2016 |
| Published | 20/10/2016 |
| Effective from | 01/04/2017 |
| Keywords | Renal insufficiency, chronic kidney disease (CKD) |
| Description | The document provides guidance on the conduct of clinical studies with medicinal products intended to prevent or slow progression of chronic renal insufficiency. It defines treatment goals, study designs, outcome measures and data analyses. |
Document history
First version Current version |
| Effective from: 01/04/2017
Published: 20/10/2016
Published: 01/07/2014
Published: 20/09/2010 |
Related content
- Directive 2001/83/EC
- Regulation (EC) No 98 726/2004
- Evaluation of the pharmacokinetics of medicinal products in patients with decreased renal function
- ICH E4 Dose response information to support drug registration
- ICH E7 Studies in support of special populations: geriatrics
- ICH E11 Clinical investigation of medicinal products in the paediatric population